Welcome to CDC stacks | Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study - 40955 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study
Filetype[PDF-462.88 KB]


Details:
  • Pubmed ID:
    26758508
  • Pubmed Central ID:
    PMC4711015
  • Description:
    Background

    The ability of tamoxifen and raloxifene to decrease breast cancer risk varies among different breast cancer subtypes. It is important to determine one’s subtype-specific breast cancer risk when considering chemoprevention. A number of single nucleotide polymorphisms (SNPs), including one in caspase-8 (CASP8), have been previously associated with risk of developing breast cancer. Because caspase-8 is an important protein involved in receptor-mediated apoptosis whose activity is affected by estrogen, we hypothesized that additional SNPs in CASP8 could be associated with breast cancer risk, perhaps in a subtype-specific manner.

    Methods

    Twelve tagging SNPs of CASP8 were analyzed in a nested case control study (1,353 cases and 1,384 controls) of non-Hispanic white women participating in the California Teachers Study. Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated for each SNP using all, estrogen receptor (ER)-positive, ER-negative, human epidermal growth factor receptor 2 (HER2)-positive, and HER2-negative breast cancers as separate outcomes.

    Results

    Several SNPs were associated with all, ER-positive, and HER2-positive breast cancers; however, after correcting for multiple comparisons (i.e., p < 0.0008), only rs2293554 was statistically significantly associated with HER2-positive breast cancer (OR = 1.98, 95 % CI 1.34-2.92, uncorrected p = 0.0005).

    Conclusions

    While our results for CASP8 SNPs should be validated in other cohorts with subtype-specific information, we conclude that some SNPs in CASP8 are associated with subtype-specific breast cancer risk. This study contributes to our understanding of CASP8 SNPs and breast cancer risk by subtype.

    Electronic supplementary material

    The online version of this article (doi:10.1186/s12885-015-2036-9) contains supplementary material, which is available to authorized users.

  • Document Type:
  • Collection(s):
  • Funding:
    HHSN261201000034C/PHS HHS/United States
    HHSN261201000035C/PHS HHS/United States
    HHSN261201000140C/PHS HHS/United States
    R01 CA77398/CA/NCI NIH HHS/United States
    U58DP003862-01/DP/NCCDPHP CDC HHS/United States
No Related Documents.
You May Also Like: